ASHP supports the Preserving Access to Life Saving Medications Act (S. 296) [PDF] cosponsored by Sens. Amy Klobuchar (D-Minn.) and Robert Casey (D-Pa.). Drug shortages in hospitals and health systems cause significant disruptions in patient care. The medications affected are often life saving drugs as well as medications used to relieve pain, to treat serious infections, and other conditions.
Congress will soon consider the Prescription Drug User Fee Act (PDUFA), legislation that contains several ASHP-supported provisions, including a requirement that drug manufacturers notify the Food and Drug Administration (FDA) when they experience a production interruption or discontinue making a drug.
Colgan Testifies on Drug Shortages [VIDEO 04:28 MIN]
Christopher J. Topoleski Director, Federal Regulatory Affairs (301) 664-8806 ctopoleski@ashp.org
Joseph Hill Director, Federal Legislative Affairs (301) 664-8710 jhill@ashp.org
©2012 American Society of Health-System Pharmacists. All rights reserved. 7272 Wisconsin Avenue, Bethesda, MD 20814 Copyright | Trademark | Privacy Policy
